Distribution of SARS-CоV-2 seroprevalence among residents of the Tyumen Region during the COVID-19 epidemic period. Journal of microbiology, epidemiology and immunobiology

Introduction. In late 2019 - early 2020, an outbreak of infection caused by a novel strain of beta coronavirus SARS-CoV-2 was reported. The World Health Organization defined the disease as coronavirus disease 2019 (COVID-19). In the Tyumen Region, the first case of COVID-19 was diagnosed on 31/1/202...

Full description

Saved in:
Bibliographic Details
Published in:Žurnal mikrobiologii, ėpidemiologii i immunobiologii Vol. 97; no. 5; pp. 392 - 400
Main Authors: Popova, Anna Yu, Ezhlova, Elena B., Melnikova, Albina A., Stepanova, Tatiana F., Sharukho, Galina V., Letyushev, Aleksandr N., Folmer, Aleksandr Ya, Shepotkova, Anna A., Lyalina, Lyudmila V., Smirnov, Vyacheslav S., Stepanova, Kseniya B., Panina, Tsakhik A., Sidorenko, Olga N., Ivanova, Natalia A., Smirnova, Svetlana S., Malchenko, Inna N., Okhotnikova, Elena V., Stakhova, Elena G., Totolian, Areg A.
Format: Journal Article
Language:English
Published: Central Research Institute for Epidemiology 03-11-2020
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction. In late 2019 - early 2020, an outbreak of infection caused by a novel strain of beta coronavirus SARS-CoV-2 was reported. The World Health Organization defined the disease as coronavirus disease 2019 (COVID-19). In the Tyumen Region, the first case of COVID-19 was diagnosed on 31/1/2020. The source of infection was a female student who came from Jinan, Shandong province (China). The number and rate of cases were steadily increasing from the 16th week through 28th week in 2020. The highest rate was 36.87 cases per 100 thousand people. Afterwards, the cumulative incidence kept increasing gradually, but not as quickly.The purpose of the seroepidemiological study was to measure the level and to identify the structure of herd immunity against the SARS-CoV-2 virus among the population of the Tyumen Region during the rapid spread of the COVID-19 outbreak.Materials and methods. Volunteers for participation in the study were selected through questionnaire surveys and random sampling. The exclusion criterion was an active COVID-19 infection at the time of the survey. A total of 2,758 individuals were tested for SARS-CoV-2 specific antibodies. The age of the surveyed volunteers ranged from 1 year to 70 years and older.Results of the study. During the active phase of the COVID-19 incidence, the population of the Tyumen Region showed moderate (24.5%) seroprevalence of SARS-CoV-2. At the same time, the tests revealed a high (97.8%) rate of asymptomatic infection cases in seropositive individuals who had never been diagnosed with COVID-19 and did not have history of positive PCR test results or acute respiratory infection symptoms on the day of testing. The maximum level of herd immunity was identified in children aged 1-6 years (34.7%), which was significantly higher compared to the average level of seroprevalence in the entire cohort. In recovered COVID-19 patients, antibodies were detected in 68.2%. In individuals with positive PCR test results, antibodies were detected in 64%. Conclusion. The results of the assessment of the level of herd immunity against the SARS-CoV-2 virus are crucial for prediction of the development trend of the epidemic and for planning specific and non-specific COVID-19 prevention measures.
ISSN:0372-9311
2686-7613
DOI:10.36233/0372-9311-2020-97-5-1